That is very good news, although this tempers it a bit:
We're in discussions to start humane phase one/two trials that would happen at the end of the summer.
Pending good results - [if] we see the drug is safe and helpful means we could start releasing it for compassionate use in September.
So six months out still. With a vaccine hopefully following another 6 months behind that. That will definitely be very good in avoiding this recurring in subsequent rounds of this virus - but unfortunately doesn't help us much with the current situation.